Tuberculosis MVA85A vaccine trial shows lack of efficacy in infants
1 April 2013. Related: TB coinfection.
TB coinfection
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
New UNITAID grants focus on paediatric HIV, TB and malaria
1 February 2013. Related: Treatment access, Paediatric care, TB coinfection.
FDA approves bedaquiline for MDR TB: first new tuberculosis drug in half a century
1 February 2013. Related: TB coinfection.
US fund additional $11 million for Xpert TB diagnostics in 14 countries
1 February 2013. Related: TB coinfection.
Costs for rapid TB test reduced by 40%
1 October 2012. Related: TB coinfection.
Important advances in TB drug development
1 October 2012. Related: TB coinfection.
Need for expanded access to two promising MDR TB drugs
1 February 2012. Related: TB coinfection.
Randomised trial of ART in TB patients with high CD4 counts
1 October 2011. Related: Conference reports, TB coinfection.
WHO Guidelines on guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
1 October 2011. Related: TB coinfection.
IPT for adults: Should the Mantoux test have been removed from WHO guidelines?
1 October 2011. Related: TB coinfection.
Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART
1 August 2011. Related: Conference reports, PK and drug interactions, TB coinfection.
The tuberculosis treatment pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
The tuberculosis diagnostic pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
The tuberculosis vaccine pipeline
14 July 2011. Related: Pipeline report, TB coinfection.
When to start ART in patients co-infected with TB: results from two trials presented at CROI
1 May 2011. Related: Conference reports, Antiretrovirals, TB coinfection.
41st Union World Conference on Lung Health, 11-15 November 2010, Berlin
1 February 2011. Related: Conference reports, TB coinfection.
Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB
1 February 2011. Related: Conference reports, TB coinfection.
Xpert MTB-RIF validation study from Tanzania
1 February 2011. Related: Conference reports, TB coinfection.
GeneXpert demonstrates good sensitivity and specificity but at high cost
1 February 2011. Related: Conference reports, TB coinfection.
Pharmacokinetics of lopinavir/ritonavir incombination with rifampicin based TB treatment in children
1 December 2010. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Tuberculosis pipeline introduction
1 July 2010. Related: Pipeline report, TB coinfection.
Tuberculosis diagnostic pipeline
1 July 2010. Related: Pipeline report, TB coinfection.
Tuberculosis treatment pipeline
1 July 2010. Related: Special reports, TB coinfection.
Tuberculosis vaccine pipeline
1 July 2010. Related: Special reports, TB coinfection.
Maternal TB, HIV and pregnancy
2 April 2010. Related: Conference reports, Women's health, Pregnancy, TB coinfection.
Overview of TB-related studies at IAS
5 October 2009. Related: Conference reports, TB coinfection.
TMC207 reduces time to sputum conversion in phase II trial on patients with drug-resistant TB
22 August 2009. Related: TB coinfection.
High rate of lost and untested TB biopsy samples and low screening for latent TB
8 June 2009. Related: Conference reports, TB coinfection.
Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children receiving rifampicin
3 June 2009. Related: Conference reports, Paediatric care, TB coinfection.
PI-based ART in children with HIV and HIV/TB coinfection in South Africa
3 June 2009. Related: Conference reports, Paediatric care, TB coinfection.
Nevirapine: fluconazole and TB treatment
20 April 2009. Related: Conference reports, TB coinfection.
WHO global TB control report highlights that 25% of TB-related deaths occur in HIV-positive people
20 April 2009. Related: TB coinfection.
Lack of efficacy of isoniazid (INH) prophylaxis and PK evaluation in South African infants
27 December 2008. Related: Conference reports, Paediatric care, TB coinfection.
Treatment outcomes in patients who received rifampicin with nevirapine or efavirenz
1 February 2008. Related: Conference reports, TB coinfection.
HIV and TB co-infection and treatment charges in the UK
1 December 2007. Related: Treatment access, TB coinfection.
Long-term effectiveness of isoniazid prophylaxis on TB incidence in a cohort of IDUs
3 July 2007. Related: Conference reports, TB coinfection.
Plasma concentrations of efavirenz and lopinavir in children with and without rifampicin-based TB treatment
4 May 2007. Related: Conference reports, Paediatric care, TB coinfection.
Extensively drug resistant TB (XTB) in South Africa
7 October 2006. Related: Conference reports, TB coinfection.
Extensively drug resistant tuberculosis: a serious wake-up call for global health
7 October 2006. Related: TB coinfection, Other news.
Global report on TB and HIV: new analysis of TB/HIV epidemics in Bangladesh, Brazil, Nigeria, Tanzania, and Thailand
7 October 2006. Related: TB coinfection, Other news.
HIV linked to lower rifampin and ethambutol AUCs in TB cohort
10 June 2006. Related: TB coinfection.
Dosing rifabutin and lopinavir/r sub-optimal rifabutin levels reported in five patients dosed according to current guidelines
12 May 2006. Related: Conference reports, PK and drug interactions, TB coinfection.
Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB
12 May 2006. Related: Conference reports, Paediatric care, TB coinfection.
NICE publishes TB guidelines in UK
12 April 2006. Related: Guidelines, TB coinfection.
WHO launches new stop TB strategy
12 April 2006. Related: TB coinfection, Other news.
Incidence of TB infection despite HAART and treatment in coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV/TB coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Efavirenz and rifampicin: lower body weight associated with higher concentrations
15 June 2005. Related: Conference reports, TB coinfection.
Responses to TB treatment in HIV positive and HIV negative patients in the UK
29 March 2005. Related: Conference reports, TB coinfection.
800mg efavirenz may not be needed with rifampicin-based TB regimens, especially in African patients
29 March 2005. Related: Conference reports, TB coinfection.
Steady state PK of nelfinavir and M8 in pregnancy
2 May 2004. Related: Conference reports, Pregnancy, PK and drug interactions, TB coinfection.
CDC study shows rifampin/pyrazinamide therapy can cause severe liver damage
1 October 2003. Related: TB coinfection.
New antibiotic appears effective against MDR-TB
1 July 2003. Related: TB coinfection.
New TB blood test shows promise
1 June 2003. Related: Diagnostics, TB coinfection.
Coinfection does not appear to augment TB infectivity
9 December 2001. Related: TB coinfection.
Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection
17 May 2001. Related: TB coinfection.